The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Narine Jeenarine since 2011.
The trader's CIK number is 1465822.
At the time of the last reporting, Narine Jeenarine was the Director of Elite Pharmaceuticals Inc /de/. (stock ticker symbol ELI).
Also see all insider trading activities at Elite Pharmaceuticals Inc /de/.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | ELTP | 0 | $0 | 4,067,908 | $2,046,423 | 0 | $0 |
| 2013 | ELTP | 0 | $0 | 5,716,486 | $594,446 | 6,032,000 | $380,016 |
| 2012 | ELTP | 0 | $0 | 3,614,300 | $338,984 | 0 | $0 |
| 2011 | ELTP | 407,949 | $16,317 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-05-09 | ELTP | Sale | 329,437 | .38 | 125,844 |
| 2014-04-02 | ELTP | Sale | 147,664 | .41 | 60,542 |
| 2014-03-27 | ELTP | Sale | 190,172 | .43 | 81,203 |
| 2014-03-11 | ELTP | Sale | 239,367 | .60 | 144,098 |
| 2014-03-06 | ELTP | Sale | 773,050 | .90 | 692,652 |
| 2014-03-07 | ELTP | Sale | 1,051,450 | .68 | 714,986 |
| 2014-01-13 | ELTP | Sale | 805,583 | .18 | 147,421 |
| 2013-01-03 | ELTP | Sale | 531,185 | .15 | 79,677 |
| 2013-12-05 | ELTP | Sale | 275,000 | .13 | 34,650 |
| 2013-11-26 | ELTP | Sale | 23,626 | .12 | 2,787 |
| 2013-11-11 | ELTP | Sale | 39,000 | .12 | 4,797 |
| 2013-11-26 | ELTP | Sale | 357,000 | .12 | 43,197 |
| 2013-11-27 | ELTP | Sale | 25,000 | .12 | 3,025 |
| 2013-11-19 | ELTP | Sale | 21,000 | .12 | 2,499 |
| 2013-11-14 | ELTP | Sale | 465,090 | .12 | 53,485 |
| 2013-11-15 | ELTP | Sale | 318,050 | .12 | 37,211 |
| 2013-11-18 | ELTP | Sale | 1,170,000 | .12 | 138,060 |
| 2013-11-06 | ELTP | Sale | 122,200 | .12 | 15,152 |
| 2013-10-28 | ELTP | Sale | 102,300 | .13 | 13,299 |
| 2013-10-29 | ELTP | Sale | 102,520 | .01 | 1,332 |
| 2013-01-22 | ELTP | Sale | 356,700 | .09 | 32,103 |
| 2013-01-14 | ELTP | Option Ex | 6,032,000 | .06 | 380,016 |
| 2013-01-11 | ELTP | Sale | 2,339,000 | .09 | 212,849 |
| 2012-12-26 | ELTP | Sale | 561,000 | .09 | 51,051 |
| 2012-12-19 | ELTP | Sale | 243,300 | .09 | 22,383 |
| 2012-03-26 | ELTP | Sale | 225,000 | .10 | 21,375 |
| 2012-03-27 | ELTP | Sale | 735,000 | .09 | 66,150 |
| 2012-03-23 | ELTP | Sale | 1,765,000 | .10 | 169,440 |
| 2012-03-16 | ELTP | Sale | 85,000 | .10 | 8,585 |
| 2011-02-03 | ELTP | Buy | 407,949 | .04 | 16,317 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Narine Jeenarine (Director of Elite Pharmaceuticals Inc /de/ at the time of this reporting) see the Securities and Exchange Commission (SEC) website.